Open fluoxetine treatment of mixed anxiety disorders in children and adolescents

Journal of Child and Adolescent Psychopharmacology

Volumn 7, Issue 1, 1997, Pages 17-29

  Fairbanks, Janet M ^a,b   Pine, Daniel S ^a   Tancer, Nancy K ^a   Steven Dummit III, E ^a   Kentgen, Lisa M ^a   Martin, Jacqueline ^a   Asche, Barbara K ^a   Klein, Rachel G ^a  

^a Columbia University ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ABDOMINAL PAIN; ADOLESCENT; AGITATION; ANOREXIA; ANXIETY NEUROSIS; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DROWSINESS; DRUG EFFICACY; FEMALE; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; OUTPATIENT; PANIC; PHOBIA; PSYCHOTHERAPY; SEPARATION ANXIETY; SLEEP DISORDER; SOCIAL PHOBIA;

EID: 0030941337     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1997.7.17     Document Type: Article

References (41)

1. Achamallah NS, Decker DH: Mania induced by fluoxetine in an adolescent patient [Letter]. Am J Psychiatry 148:1404, 1991
2. Achenbach TM, Howell CT, McConaughy SH, Stanger C: Six-year predictors of problems in a national sample of children and youth: I. Cross-informant syndromes. J Am Acad Child Adolesc Psychiatry 34:336-347, 1995
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington (DC), American Psychiatric Association, 1988
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington (DC), American Psychiatric Association, 1994
5. Benjamin RS, Costello EJ, Warren M: Anxiety disorders in a pediatric sample. J Anxiety Disord 4:293-316, 1990
6. Bernstein GA, Borchardt CM, Perwien AR: Anxiety disorders in children and adolescents: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 35:1110-1119, 1996
7. Bird HR, Canino G, Rubio-Stipec M, Ribera JC: Further measures of the psychometric properties of the Children's Global Assessment Scale. Arch Gen Psychiatry 44:821-824, 1987
8. Birmaher B, Waterman GS, Ryan N, Cully M, Balach L, Ingram J, Brodsky M: Fluoxetine for childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 33:993-999, 1994
9. Black B, Uhde TW: Treatment of elective mutism with fluoxetine: A double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 33:847-856, 1994
10. Cook EH, Rowlett R, Jaselskis B, Leventhal BL: Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry 31:739-745, 1992
11. Costello EJ, Angold A: Epidemiology. In: Anxiety Disorders in Children and Adolescents. Edited by March JM. New York, Guilford Press, 1995, pp 109-124
12. Devaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist JH, Reichler R, Katz R, Landau P: Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder. A multicenter trial. J Am Acad Child Adolesc Psychiatry 31:45-49, 1992
13. Dummit ES, Klein RG, Tancer NK, Asche B, Martin J: Fluoxetine treatment of children with selective mutism: An open trial. J Am Acad Child Adolesc Psychiatry 35:615-621, 1996
14. Ferdinand RF, Verhulst FC: Psychopathology from adolescence into young adulthood: An eight-year follow-up study. Am J Psychiatry 152:1586-1594, 1995
15. Fleiss JL: Statistical Methods for Rates and Proportions, Second Edition. New York, Wiley, 1981
16. Geller DA, Biederman J, Reed ED, Spencer T, Wilens TE: Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 34:36-44, 1995
17. Goodman WK, Kozak MJ, Liebowitz M, White KL: Treatment of obsessive-compulsive disorder with fluvoxamine: A multicentre, double-blind, placebo-controlled trial. Intl Clin Psychopharmacol 11:21-29, 1996
18. Gurley D, Cohen P, Pine DS, Brook J: Discriminating anxiety and depression in youth: A role for diagnostic criteria. J Affect Disord 39:191-200, 1996
19. Guy W: ECDEU Assessment Manual of Psychopharmacology. DHEW Publication ADM 76-338. Rockville (MD), National Institute of Mental Health, Psychopharmacology Research Branch, 1976
20. Ialongo N, Edelshon G, Werthamer-Larsson L, Kellam S: The significance of self-reported anxious symptoms in first grade children. J Abnorm Child Psychol 22:441-455, 1994
21. Ialongo N, Edelshon G, Werthamer-Larsson L, Crockett L, Kellam S: The significance of self-reported anxious symptoms in first grade children: Prediction to anxious symptoms and adaptive functioning in fifth grade. J Child Psychol Psychiatry 36:427-437, 1995
22. Jerome L: Hypomania with fluoxetine. J Am Acad Child Adolesc Psychiatry 30:850-851, 1991
23. Katzelnick DJ, Kobak KA, Greis JH, Jefferson JW, Mantle JM, Serlin RC: Sertraline for social phobia: A double-blind, placebo-controlled crossover study. Am J Psychiatry 152:1368-1371, 1995
24. Kentgen L, Klein RG, Manuzza S, Davies M: Test-retest reliability of maternal reports of lifetime mental disorders in children. J Abn Child Psychol, In press
25. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshsleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19, 1994
26. Klein R, Mannuzza S: Parent as Respondent Informant Schedule (PARIS). New York, New York State Psychiatric Institute, 1992
27. Klein RG: Anxiety disorders. In: Child and Adolescent Psychiatry: Modern Approaches, Third Edition. Edited by Rutter M, Taylor E, Hersov L. Oxford, Blackwell Scientific Publications, 1994a, pp 351-374
28. Klein RG, Abikoff H, Barkley RA, Campbell M, Leckman JF, Ryan ND, Solanto MV, Whalen CK: Clinical trials in children and adolescents. In: Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines. Edited by Prien RF, Robinson DS. New York, Raven Press, 1994b, pp 501-546
29. LaGreca AM, Stone WL: Social anxiety scale for children - revised: Factor structure and concurrent validity. J Clin Child Psychol 22:17-27, 1993
30. Liebowitz MR: Social phobia. Mod Probl Pharmacopsychiatry 22:141-173, 1987
31. March J (ed): Anxiety Disorders in Children and Adolescents. New York, Guilford Press, 1995
32. Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J, Calberg H, Judge R, Ohrstrom JK, Manniche PM: Paroxetine in the treatment of panic disorder. A randomized, double-blind, placebo-controlled study. Br J Psychiatry 167:374-379, 1995
33. Pine DS, Cohen P, Gurley D, Brook JS: The association between emotional disorders in children and adults: Results from a prospective epidemiological study [Abstract]. Scientific Proceedings of the 43rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Philadephia, 1996
34. Riddle MA, King RA, Hardin MT, Scahill L, Ort SI, Chappell P, Rasmusson A, Leckman JF: Behavioral side effects of fluoxetine in children and adolescents. J Child Adolesc Psychopharmacol 1:193-198, 1991
35. Riddle MA, Scahill L, King RA, Hardin MT, Anderson CM, Ort SI, Smith JC, Leckman JF, Cohen DJ: Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 31:1062-1069, 1992
36. Rosenberg DR, Johnson K, Sahl R: Evolving mania in an adolescent treated with low-dose fluoxetine. J Child Adolesc Psychopharmacol 2:299-306, 1992
37. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: A children's global assessment scale (GAS). Arch Gen Psychiatry 40:1228-1231, 1983
38. Shaffer DS, Fisher P, Dulcan M, Davies M, Piacentini J, Schwab-Stone M, Lahey B, Bourdon K, Jensen P, Bird H, Canino G, Regier DA: The NIMH Diagnostic Interview Schedule for Children (DISC 2.3): Description, acceptability, prevalence rates, and performance in the MECA study. J Am Acad Child Adolesc Psychiatry 35:865-877, 1996
39. Van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G: Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 55(12):517-522, 1994
40. Venkataraman S, Naylor MW, King CA: Mania associated with fluoxetine treatment in adolescents. J Am Acad Child Adolesc Psychiatry 31:276-281, 1992
41. Watson D, Friend R: Measurement of social-evaluative anxiety. J Consult Clin Psychol 33:448-457, 1969